Are existing validated severity scores for epidermolysis bullosa reflective of the burden of disease in patients with epidermolysis bullosa simplex?

Clin Exp Dermatol. 2023 Jun 5;48(6):706-707. doi: 10.1093/ced/llad069.

Authors

Manrup K Hunjan^{1

2}, Ajoy Bardhan^{1

3}, Louise Zuzarte¹, Dario Leonardo Balacco³, Natasha Harper¹, Adrian Heagerty^{1

4}

Affiliations

¹ National Adult Epidermolysis Bullosa Service, Solihull Hospital, University Hospitals Birmingham NHS Foundation Trust, Solihull, UK.
² College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
³ Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
⁴ Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.

PMID: 36972307
DOI: 10.1093/ced/llad069

No abstract available

MeSH terms

Cost of Illness
Epidermolysis Bullosa Simplex* / complications
Epidermolysis Bullosa Simplex* / diagnosis
Epidermolysis Bullosa Simplex* / genetics
Epidermolysis Bullosa* / complications
Humans
Mutation
Patients

Grants and funding

DEBRA